Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Newly Available Treatment Option for Inflammation After Cataract Surgery

Eric D. Donnenfeld, MD, joins Neda Shamie, MD, to discuss the results of a phase 3 multicenter study of IBI-10090 anterior chamber dexamethasone drug-delivery suspension (Dexycu, EyePoint Pharmaceuticals). How did this agent compare to prednisolone acetate 1.0% ophthalmic drops for treating inflammation after cataract surgery?

To access the full study, please visit the link here:

Cataract Surgery • Inflammation

9 / 37 Series: Clinical Minute

More Videos in this Series